Abstract
In drug discrimination (DD) procedures, behavior is differentially reinforced depending on the presence or absence of specific drug stimuli. The DD paradigm has been widely adopted by behavioral pharmacologists because of its specificity of stimulus control, concordance with drug action at cellular levels and its use as a preclinical model of subject-rated effects in humans. With the successful extension of DD to humans, a comparison of human and nonhuman DD will help place each in the context of the other. Twenty-eight studies of DD in humans are reviewed, including studies of amphetamine, opioid, benzodiazepine, caffeine, nicotine, marijuana and ethanol discriminative stimuli. Comparison of procedures between studies in humans and nonhumans reveals a common tradition, except the use of instructions appears to facilitate greatly DD acquisition in humans. Findings were qualitatively similar between humans and nonhumans. Potency relationships were quantitatively similar between humans and most, but not all, other species. Areas of human DD needing additional empirical evaluation include the influence of instructions, the effects of training dose and the effects of antagonists. Additionally, antihistamines, barbiturates, nicotine and marijuana are under-represented in human DD.
Similar content being viewed by others
References
Altman JL, Albert JM, Milstein SL, Greenberg I (1977) Drugs as discriminable events in humans. In: Lal H (ed) Discriminative stimulus properties of drugs. Plenum Press, New York, pp 187–206
Amrick CL, Bennett DA (1987) A comparison of diazepam stimuli in aged and adult rats. Psychopharmacology 93:292–295
Ator NA, Griffiths RR (1983) Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788. J Pharmacol Exp Ther 226:776–782
Ator NA, Griffiths RR (1986) Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J Pharmacol Exp Ther 237:393–403
Ator NA, Griffiths RR (1989) Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam. Psychopharmacology 98:20–30
Bickel WK, Bigelow GE, Preston KL, Liebson IA (1989) Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect. J Pharmacol Exp Ther 251:1053–1063
Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR (1993) A novel-response procedure enhances the specificity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exp Ther 264:360–367
Bois C, Vogel-Sprott M (1974) Discrimination of low blood alcohol levels and self-titration skills in social drinkers. Q J Stud Alcohol 35:86–87
Chait LD, Johanson CE (1988) Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Psychopharmacology 96:302–308
Chait LD, Evans SM, Grant KA, Kamien JB, Johanson CE, Schuster CR (1988) Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 94:206–212
Chait LD, Uhlenhuth EH, Johanson CE (1984) An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology 82:272–274
Chait LD, Uhlenhuth EH, Johanson CE (1985) The discriminative stimulus and subjective effects ofd-amphetamine in humans. Psychopharmacology 86:307–312
Chait LD, Uhlenhuth EH, Johanson CE (1986a) The discriminative stimulus and subjective effects ofd-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology 89:301–306
Chait LD, Uhlenhuth EH, Johanson CE (1986b) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol andd-amphetamine in humans. Pharmacol Biochem Behav 24:1665–1672
Chait LD, Uhlenhuth EH, Johanson CE (1989) Individual differences in the discriminative stimulus effects ofd-amphetamine in humans. Drug Dev Res 16:451–460
Colpaert FC, Janssen PAJ (1982) OR discrimination: a new drug discrimination method. Eur J Pharmacol 78:141–144
Colpaert FC, Niemegeers CJE, Janssen PAJ (1975) The narcotic cue: evidence for the specificity of the stimulus properties of narcotic drugs. Arch Int Pharmacodyn 218:268–276
Colpaert FC, Desmedt LKC, Janssen PAJ (1976) Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; relation to some intrinsic and anticonvulsant effects. Eur J Pharmacol 37:113–123
Colpaert FC, Niemegeers CJE, Janssen PAJ (1980) Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination. Neuropharmacology 19:705–713
Conger JJ (1951) The effects of alcohol on conflict behavior in the albino rat. Q J Stud Alcohol 12:1–29
Craft RM, Howard JL (1988) Cue properties of oral and transdermal nicotine in the rat. Psychopharmacology 96:281–284
Evans SM, Griffiths RR (1991) Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Pharmacol 2:345–356
Evans SM, Johanson CE (1986) The discriminative stimulus properties of histamine H1 antagonists ind-amphetamine-trained and midazolam-trained pigeons. NIDA Res Monogr 76:214–220
Evans SM, Johanson CE (1987) Amphetamine-like effects of anorectics and related compounds in pigeons. J Pharmacol Exp Ther 241:817–825
Evans SM, Johanson CE (1989) Discriminative stimulus properties of midazolam in the pigeon. J Pharmacol Exp Ther 248:29–38
France CP, Woods JH (1985) Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure. J Pharmacol Exp Ther 234:81–89
France CP, Woods JH (1987) Beta-funaltrexamine antagonises the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharmacology 91:213–216
France CP, Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J Pharmacol Exp Ther 254:626–632
France CP, Jacobsen AE, Woods JH (1984) Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine. J Pharmacol Exp Ther 230:652–657
Garcha HS, Rose IC, Stolerman IP (1985) Midazolam cue in rats: generalization tests with anxiolytics and other drugs. Psychopharmacology 87:233–237
Garza R de la, Johanson CE (1987) Discriminative stimulus properties of intragastrically administeredd-amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther 243:955–962
Gauvin DV, Holloway FA (1991) Historical factors in the development of ETOH-conditioned place preference. Alcohol 9:1–7
Goudie AJ, Leathley M, McNally J, West CR (1989) Individual differences in cocaine discrimination. Drug Dev Res 16:123–131
Grant KA, Barrett JE (1991) Blockade of the discriminative stimulus effects of ethanol with 5-HT3-receptor antagonists. Psychopharmacology 104:451–456
Grant KA, Knisely JS, Tabakoff B, Barrett JE, Balster RL (1991) Ethanol-like discriminative stimulus effects of non-competative n-methyl-d-aspartate antagonists. Behav Pharmacol 2:87–95
Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990) Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther 252:970–978
Harris CM, Emmett-Oglesby MW, Lal H (1989) Sensitivity of pentylenetetrazol discrimination increased by a stimulus fading technique. Psychopharmacology 98:460–464
Haug T (1983) Neuropharmacological specificity of the diazepam stimulus complex: effects of agonists and antagonists. Eur J Pharmacol 93:221–227
Haug T, Gotestam KG (1982) Onset and offset of the diazepam stimulus complex. Pharmacol Biochem Behav 17:1171–1174
Hazell P, Peterson DW, Laverty R (1978) Inability of hexamethonium to block the discriminative stimulus (Sd) property of nicotine. Pharmacol Biochem Behav 9:137–140
Heishman SJ, Henningfield JE (1991) Discriminative stimulus effects ofd-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology 103:436–442
Hendry JS, Balster RL, Rosecrans JA (1983) Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats. Pharmacol Biochem Behav 19:97–101
Herling S, Shannon HE (1982) Ro 15-1788 antagonizes the discriminative stimulus effects of diazepam in rats but not similar effects of pentobarbital. Life Sci 31:2105–2112
Hiltunen AJ, Jarbe TUC (1986) Discrimination of Ro 11-6896, chlordiazepoxide and ethanol in gerbils: generalization and antagonism tests. Psychopharmacology 89:284–290
Hiltunen AJ, Jarbe TUC (1989) Discriminative stimulus properties of ethanol: effects of cumulative dosing and RO 15-4513. Behav Pharmacol 1:133–140
Hiltunen AJ, Jarbe TUC, Hellström-Lindahl E, Croon LB, Jones AW (1989) Concentrations of ethanol in rebreathed air of rats: correlation with the discriminative stimulus effects of ethanol. Alcohol 6:39–43
Hoffmeister F (1988) A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine. Psychopharmacology 94:315–320
Holloway FA, Michaelis RC, Huerta PL (1985) Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. Life Sci 36:723–730
Holtzman SG (1985) Drug Discrimination Studies. Drug Alcohol Depend 14:263–282
Holtzman SG, Locke KW (1988) Neural mechanisms of drug stimuli: experimental approaches. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, pp 139–153
Huang JT, Ho BT (1974) Discriminative stimulus properties ofd-amphetamine and related compounds in rats. Pharmacol Biochem Behav 2:669–673
Huber H, Karlin R, Nathan PE (1976) Blood alcohol level discrimination by nonalcoholics. J Stud Alcohol 37:27–39
Jarbe TUC, Kroon ER (1980) Discriminative properties ofd-amphetamine in gerbils: tests for drug generalization and antagonism. Gen Pharmacol 11:153–156
Jarbe TUC, Hiltunen AJ, Swedberg MDB (1982) Ethanol as a discriminative stimulus: effects of cyanamide, acetaldehyde and chlormethiazole. Med Biol 60:298–306
Johanson CE (1991a) Further studies on the discriminative stimulus effects of diazepam in humans. Behav Pharmacol 2:357–367
Johanson CE (1991b) The discriminative stimulus effects of diazepam in humans. J Pharmacol Exp Ther 257:634–643
Kallman WM, Kallman MJ, Harry GJ, Woodson PP, Rosencrans JA (1982) Nicotine as a discriminative stimulus in human subjects. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, New York, pp 211–218
Krimmer EC, Barry HIII (1990) Ethanol interoceptive cue and sleep-time duration in HAS and LAS selectively bred rats. Pharmacol Biochem Behav 36:255–260
Kuhn DM, Appel JB, Greenberg I (1974) An analysis of some discriminative properties ofd-amphetamine. Psychopharmacologia 39:57–66
Lansky D, Nathan PE, Lawson DM (1978) Blood alcohol discrimination by alcoholics: the role of internal and external cues. J Consult Clin Psychol 46:953–960
Lee F, Stafford I, Hoebel BG (1989) Similarities between the stimulus properties of phenylpropanolamine and amphetamine. Psychopharmacology 97:410–412
Lipscomb TR, Nathan PE (1980) Blood alcohol level discrimination. The effects of family history of alcoholism, drinking pattern, and tolerance. Arch Gen Psychiatry 37:571–576
Lovibond SH, Caddy G (1970) Discriminated aversive control in the moderation of alcoholics' drinking behavior. Behav Ther 1:437–444
Maisto SE, Adesso VA (1977) Effect of instructions and feedback on blood alcohol level discrimination training in nonalcoholic drinkers. J Consult Clin Psychol 45:625–636
Modrow HE, Holloway FA, Carney JM (1981) Caffeine discrimination in the rat. Pharmacol Biochem Behav 14:683–688
Morrison CF, Stephenson JA (1969) Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia 15:351–360
Mumford GK, Holtzman SG (1991) Qualitative Differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857–865
Negus SS, Picker MJ, Dykstra LA (1991) Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey. J Pharmacol Exp Ther 256:149–158
Nierenberg J, Ator NA (1990) Drug discrimination in rats successively trained to discriminate diazepam and pentobarbital. Pharmacol Biochem Behav 35:405–412
Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Fenwick JW (1992a) Triazolam as a discriminative stimulus in humans. Drug Alcohol Depend 30:133–142
Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992b) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885–894
O'Neal MF, Means LW, Porter JH, Rosecrans JA, Mokler DJ (1988) Rats that acquire a THC discrimination more rapidly are more sensitive to THC and faster in reaching operant criteria. Pharmacol Biochem Behav 29:67–71
Overton DA (1966) State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacology 10:6–31
Overton DA (1979) Drug discrimination training with progressively lowered doses. Science 205:720–721
Paule MG, Wenger GR (1986) Morphine discrimination in the pigeon using a color tracking procedure. Pharmacol Biochem Behav 24:597–604
Picker MJ, Dykstra LA (1989) Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. J Pharmacol Exp Ther 249:557–566
Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA (1990) Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther 254:13–22
Porsolt RD, Pawelec C, Jalfre M (1982) Use of drug discrimination procedure to detect amphetamine-like effects of antidepressants. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, New York, pp 193–202
Preston KL, Bigelow GE, Bickel W, Liebson IA (1987) Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. J Pharmacol Exp Ther 243:1002–1009
Preston KL, Bigelow GE, Bickel WK, Liebson IA (1989) Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 250:184–196
Preston KL, Bigelow GE, Liebson IA (1990) Discrimination of butorphanol and nalbuphine in opioid-dependent humans. Pharmacol Biochem Behav 37:511–522
Preston KL, Liebson IA, Bigelow GE (1992) Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination. J Pharmacol Exp Ther 261:62–71
Priestley T (1983) Buprenorphine: stimulus generalisation to morphine — evidence for an action at the opiate mu-receptor. Br J Pharmacol 79:276P
Rees DC, Balster RL (1988) Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice. J Pharmacol Exp Ther 244:592–598
Rees DC, Knisely JS, Breen TJ, Balster RL (1987) Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J Pharmacol Exp Ther 243:931–937
Reidenberg, MM (1991) Effect of the requirement for triplicate prescriptions for benzodiazepines in New York State. Clin Pharmacol Ther 50:129–131
Rosen JB, Young AM, Beuthin FC, Louis-Ferdinand RT (1986) Discriminative stimulus properies of amphetamine and other stimulants in lead-exposed and normal rats. Pharmacol Biochem Behav 24:211–215
Samele C, Shine PJ, Stolerman IP (1992) A bibliography of drug discrimination research 1989–1991. Behav Pharmacol 3:171–192
Sanger DJ (1988) Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, pp 73–84
Schaefer GJ, Holtzman SG (1981) Morphine-like stimulus effects in the monkey: opioids with antagonist properties. Pharmacol Biochem Behav 14:241–245
Schechter MD (1977) Caffeine potentiation of amphetamine: implications for hyperkinesis therapy. Pharmacol Biochem Behav 6:359–361
Schechter MD (1983) Drug sensitivity of individual rats determines degree of drug discrimination. Pharmacol Biochem Behav 19:1–4
Schechter MD, Finkelstein JA (1985) Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats. Pharmacol Biochem Behav 23:7–11
Schechter MD, Rosecrans JA (1972) Nicotine as a discriminative stimulus: inability of related drugs to produce a nicotine-like cueing effect. Psychopharmacologia 27:379–387
Schechter MD, Rosecrans JA (1973)d-Amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol 21:212–216
Schechter MD, Signs SA, Boja JW (1989) Stability of the stimulus properties of drugs over time. Pharmacol Biochem Behav 32:361–364
Schuster CR, Johanson CE (1988) The relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, pp 161–175
Shannon HE (1984) Stimulus control by diazepam of behavior maintained under fixed-ratio stimulus-shock termination schedules in rats. Pharmacol Biochem Behav 20:715–720
Shannon HE, Herling S (1983) Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J Pharmacol Exp Ther 227:160–166
Shannon HE, Holtzman SG (1976) Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Psychopharmacology 50:119–124
Shannon HE, Holtzman SG (1977) Further evaluation of the discriminative effects of mophine in the rat. J Pharmacol Exp Ther 201:55–66
Shannon HE, Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology 61:239–244
Shannon HE, Cone EJ, Gorodetzky CW (1984) Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone. J Pharmacol Exp Ther 229:768–774
Shapiro AP, Nathan PE, Hay WM, Lipscomb TR (1980) Influence of dosage level on blood alcohol level discrimination by alcoholics. J Consult Clin Psychol 48:655–656
Shearman GT, Herz A (1982) Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate k-receptor agonists. Psychopharmacology 78:63–66
Signs SA, Schechter MD (1988) The role of dopamine and serotonin receptors in the mediation of the ethanol interoceptive cue. Pharmacol Biochem Behav 30:55–64
Silverman K, Griffiths RR (1992) Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J Exp Anal Behav 57:91–107
Silverman PB, Ho BT (1980) The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine. Psychopharmacology 68:209–215
Silverstein SJ, Nathan PE, Taylor HA (1974) Blood alcohol level estimation and controlled drinking by chronic alcoholics. Behav Ther 5:1–15
Spealman RD (1985) Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by RO 15-1788. J Pharmacol Exp Ther 235:456–462
Stolerman IP (1991) Measures of stimulus generalization in drug discrimination experiments. Behav Pharmacol 2:265–282
Stolerman IP, D'Mello GD (1981) Role of training conditions in discrimination of central nervous system stimulants in rats. Psychopharmacology 73:295–303
Takada K, Hagen TJ, Cook JM, Goldberg SR, Katz JL (1988) Discriminative stimulus effects of intravenous nicotine in squirrel monkeys. Pharmacol Biochem Behav 30:243–247
Tang AH, Franklin SR (1991) The discriminative stimulus effects of diazepam in rats at two training doses. J Pharmacol Exp Ther 258:926–931
White M, Holtzman SG (1981) Three-choice drug discrimination in the rat: morphine, cyclazocine and saline. J Pharmacol Exp Ther 217:254–262
White M, Holtzman SG (1983) Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties. J Pharmacol Exp Ther 224:95–99
Wilson MC, Buelke J (1978) Discriminative properties ofl-amphetamine: stimulus generalization. In: Ho BT, Richards DWIII, Chute DL (eds) Drug discrimination and state dependent learning. Academic Press, New York, pp 47–66
Winter JC (1981) Caffeine-induced stimulus control. Pharmacol Biochem Behav 15:157–159
Woolverton WL, Johanson CE, Garza R de la, Ellis S, Seiden LS, Schuster CR (1986) Behavioral and neurochemical evaluation of phenylpropanolamine. J Pharmacol Exp Ther 237:926–930
Woudenberg F, Slangen JL (1989) Discriminative stimulus properties of midazolam: comparison with other benzodiazepines. Psychopharmacology 97:466–470
York JL (1978a) A comparison of the discriminative stimulus effects of ethanol, barbital and phenobarbital in rats. Psychopharmacology 60:19–23
York JL (1978b) Efficacy of ethanol as a discriminative stimulus in ethanol-preferring and ethanol-nonpreferring rats. Experientia 34:224–225
York JL (1981) The ethanol stimulus in rats with differing ethanol preferences. Psychopharmacology 74:339–343
York JL, Bush R (1982) Studies on the discriminative stimulus properties of ethanol in squirrel monkeys. Psychopharmacology 77:212–216
Young AM, Stephens KR, Hein DW, Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther 229:118–126
Young R, Glennon RA (1987) Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR). Psychopharmacology 93:529–533
Young R, Urbancic A, Emrey TA, Hall PC, Metcalf G (1987) Behavioral effects of several new anxiolytics and putative anxiolytics. Eur J Pharmacol 143:361–371
Zenick H, Goldsmith M (1981) Drug discrimination learning in lead-exposed rats. Science 212:569–571
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamien, J.B., Bickel, W.K., Hughes, J.R. et al. Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology 111, 259–270 (1993). https://doi.org/10.1007/BF02244940
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244940